2026 session. Prime sponsor: Yury Polozov (R). Status: Sent to interim study.
Starting January 1, 2027, hospitals and clinics in the federal 340B discounted drug program with a New Hampshire address would report yearly to the Department of Health and Human Services and the attorney general. Reports cover drug costs and payments, use of savings, charity care, and patients sent to collections. The data would stay confidential, and the department would publish an aggregated report. Late reports would be fined $1,000 per day.
The House referred the bill to the Health, Human Services and Elderly Affairs Committee, which voted 18-0 on January 28, 2026 to send it to interim study. The House approved that by voice vote on February 12. On October 22, 2026, the interim study report found it not recommended for future legislation, by a vote of 12-1.